Raynaud's phenomenon and systemic diseases: immunological viewpoint
Lantin, J.P.; Duc, J.
Revue Medicale de la Suisse Romande 112(5): 401-404
1992
ISSN/ISBN: 0035-3655 PMID: 1604100 Document Number: 395910
Document emailed within 1 workday
Related Documents
Varela-Aguilar, J.M.; Sánchez-Román, J.; Talegón Meléndez, A.; Castillo Palma, M.J. 1997: Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex Revista Clinica Espanola 197(2): 77-83Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763
Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Della Bella, S.; Molteni, M.; Mocellin, C.; Fumagalli, S.; Bonara, P.; Scorza, R. 2001: Lymphocyte-endothelium interaction in systemic sclerosis and Raynaud's phenomenon Clinical and Experimental Rheumatology 19(6): 647-654
Porciello, G.; Scarpato, R.; Ferri, C.; Storino, F.; Cagetti, F.; Morozzi, G.; Bellisai, F.; Migliore, L.; Marcolongo, R.; Galeazzi, M. 2003: Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon Journal of Rheumatology 30(6): 1244-1247
Abou-Raya, A.; Abou-Raya, S.; Helmii, M. 2008: Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers Journal of Rheumatology 35(9): 1801-1808
Kallenberg, C.G.; Wouda, A.A.; The, T.H. 1984: Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis? Netherlands Journal of Medicine 27(9): 322-326
Ranieri, G.; De Mitrio, V.; Petronelli, M.; Ancona, A.; Dammacco, F. 1988: Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia La Clinica Terapeutica 126(5): 335-343
Kahan, A.; Weber, S.; Amor, B.; Menkes, C.J.; Hodara, M.; Degeorges, M. 1985: Nifedipine and Raynaud's phenomenon associated with connective tissue diseases International Angiology: a Journal of the International Union of Angiology 4(2): 221-223
Buryĭ, V.T.; Buryĭ, V.V. 2008: The treatment of neurospastic vascular diseases in Raynaud phenomenon Klinichna Khirurhiia 6: 36-39
Kumagai, S.; Morinobu, A.; Ozaki, S.; Nakao, K.; Ishida, H. 1998: Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases Ryumachi 38(3): 504-510
Maricq, H.R.; Diat, F.; Weinrich, M.C.; Maricq, J.G. 1994: Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon Journal of Rheumatology 21(8): 1472-1476
Kawald, A.; Burmester, G.R.; Huscher, D.ör.; Sunderkötter, C.; Riemekasten, G. 2008: Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study Journal of Rheumatology 35(9): 1830-1837
Shcherbakov, A.B. 1988: Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists Vutreshni Bolesti 27(6): 55-58
Hagège, A.A. 1986: Raynaud's phenomenon Revue de l'Infirmiere 36(8): 16-17
Clément, D.L. 1980: Raynaud's phenomenon Revue Medicale de Liege 35(19): 633-634
Ratner, G.L.; Slutsker, G.E. 1991: Raynaud's phenomenon Khirurgiia 6: 36-40
Piérard-Franchimont, C.; Piérard, G.E.; Hermanns-Lê, T. 2012: Raynaud's phenomenon Revue Medicale de Liege 67(12): 655-659
Allegra, C.; Criscuolo, A.; Pollari, G.; Bonifacio, M.; Nunes, P. 1983: Pharmacotherapy of Raynaud's phenomenon Minerva Cardioangiologica 31(9): 465-468
Lazareth, I. 2001: Management of Raynaud's phenomenon Annales de Dermatologie et de Venereologie 128(4): 553-556